Yahoo! Finance: Top Stories

Oppenheimer Hikes Ascendis Pharma Price Target on Strong Yorvipath Demand Outlook

Jun 24, 2025 - 10:18
 0
Oppenheimer Hikes Ascendis Pharma Price Target on Strong Yorvipath Demand Outlook
Read More

Tags:

Previous Article

Piper Sandler Reaffirms Overweight Rating on BridgeBio Ahead of Phase 3 CALIBRAT...

Next Article

Jefferies Lifts United Airlines Price Target Despite Newark Challenges

Related Posts

Jim Cramer Says You Should Buy UnitedHealth Group (UNH)

Jim Cramer Says You Should Buy UnitedHealth Group (UNH)

May 14, 2025  0

Here's How You Can Earn $100 In Passive Income By Investing In Air Products And Chemicals Stock

Here's How You Can Earn $100 In Passive Income By Inves...

Jun 8, 2025  0

Jim Cramer on Chevron (CVX) – “Like Oil? Then Chevron’s a Terrific Place to Be with That 4.8% Yield”

Jim Cramer on Chevron (CVX) – “Like Oil? Then Chevron’s...

May 14, 2025  0